Departments of Pathology and

The immune response HLA class II DRB1 gene provides the major genetic contribution to Juvenile Idiopathic Arthritis (JIA), with a hierarchy of predisposing through intermediate to protective effects. With JIA, and the many other HLA associated diseases, it is difficult to identify the combinations of biologically relevant amino acid (AA) residues directly involved in disease due to the high level of HLA polymorphism, the pattern of AA variability, including varying degrees of linkage disequilibrium (LD), and the fact that most HLA variation occurs at functionally important sites. In a subset of JIA patients with the clinical phenotype oligoarticular-persistent (OP), we have applied a recently developed novel approach to genetic association analyses with genes/proteins sub-divided into biologically relevant smaller sequence features (SFs), and their "alleles" which are called variant types (VTs). With SFVT analysis, association tests are performed on variation at biologically relevant SFs based on structural (e.g., beta-strand 1) and functional (e.g., peptide binding site) features of the protein. We have extended the SFVT analysis pipeline to additionally include pairwise comparisons of DRB1 alleles within serogroup classes, our extension of the Salamon Unique Combinations algorithm, and LD patterns of AA variability to evaluate the SFVT results; all of which contributed additional complementary information. With JIA-OP, we identified a set of single AA SFs, and SFs in which they occur, particularly pockets of the peptide binding site, that account for the major disease risk attributable to HLA DRB1. These are (in numeric order): AAs 13 (pockets 4 and 6), 37 and 57 (both pocket 9), 67 (pocket 7), 74 (pocket 4), and 86 (pocket 1), and to a lesser extent 30 (pockets 6 and 7) and 71 (pockets 4, 5, and 7).

[1]  S. McWeeney,et al.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method. , 1997, American journal of human genetics.

[2]  A. Valdés,et al.  Searching for additional disease loci in a genomic region. , 2008, Advances in genetics.

[3]  C. Sylvester-Hvid,et al.  One-Pot, Mix-and-Read Peptide-MHC Tetramers , 2008, PloS one.

[4]  H. Payami,et al.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. , 1989, American journal of human genetics.

[5]  E. Thorsby,et al.  Invited anniversary review: HLA associated diseases. , 1997, Human immunology.

[6]  J. Imboden The immunopathogenesis of rheumatoid arthritis. , 2009, Annual review of pathology.

[7]  Carl D Langefeld,et al.  Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. , 2010, Arthritis and rheumatism.

[8]  Lawrence Hunter,et al.  Pacific symposium on biocomputing 2006 , 2005, PSB 2016.

[9]  Søren Brunak,et al.  Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach , 2004, Bioinform..

[10]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[11]  Steven J Mack,et al.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. , 2008, Human immunology.

[12]  G. Thomson,et al.  How selection shapes variation of the human major histocompatibility complex: a review , 2001, Annals of human genetics.

[13]  P. Bingley,et al.  Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. , 2007, Tissue antigens.

[14]  P. Hedrick,et al.  Gametic disequilibrium measures: proceed with caution. , 1987, Genetics.

[15]  S. Lewis,et al.  Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. , 2010, Human molecular genetics.

[16]  C. H. WADDINGTON,et al.  Advances in Genetics , 1947, Nature.

[17]  B. Bainbridge,et al.  Genetics , 1981, Experientia.